ACCESSWIRE

Levi & Korsinsky, LLP

Share

CLASS ACTION UPDATE for PRVB, WPG and RCAR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / July 19, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

PRVB Shareholders Click Here: https://www.zlk.com/pslra-1/provention-bio-inc-loss-submission-form?prid=17762&wire=1
WPG Shareholders Click Here: https://www.zlk.com/pslra-1/washington-prime-group-inc-information-request-form?prid=17762&wire=1
RCAR Shareholders Click Here: https://www.zlk.com/pslra-1/renovacare-inc-information-request-form?prid=17762&wire=1

* ADDITIONAL INFORMATION BELOW *

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

Provention Bio, Inc. (NASDAQ:PRVB)

PRVB Lawsuit on behalf of: investors who purchased November 2, 2020 - April 8, 2021
Lead Plaintiff Deadline: July 20, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/provention-bio-inc-loss-submission-form?prid=17762&wire=1

According to the filed complaint, during the class period, Provention Bio, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the teplizumab Biologics License Application ("BLA") was deficient in its submitted form and would require additional data to secure U.S. Food and Drug Administration approval; (ii) accordingly, the teplizumab BLA lacked the evidentiary support the Company had led investors to believe it possessed; (iii) the Company had thus overstated the teplizumab BLA's approval prospects and hence the commercialization timeline for teplizumab; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Washington Prime Group, Inc. (NYSE:WPG)

WPG Lawsuit on behalf of: investors who purchased November 5, 2020 - March 4, 2021
Lead Plaintiff Deadline: July 23, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/washington-prime-group-inc-information-request-form?prid=17762&wire=1

According to the filed complaint, during the class period, Washington Prime Group, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) WPG's financial condition was deteriorating substantially; (2) as a result, there was substantial uncertainty about the Company's ability to meet its capital structure obligations as they became due; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Renovacare, Inc. (OTC PINK:RCAR)

RCAR Lawsuit on behalf of: investors who purchased August 14, 2017 - May 28, 2021
Lead Plaintiff Deadline: September 14, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/renovacare-inc-information-request-form?prid=17762&wire=1

According to the filed complaint, during the class period, Renovacare, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) at the direction of Harmel Rayat, RenovaCare engaged in a promotional campaign to issue misleading statements to artificially inflate the Company's stock price; (2) when the OTC Markets inquired, RenovaCare and Mr. Rayat issued a materially false and misleading press release claiming that no director, officer, or controlling shareholder had any involvement in the purported third party's promotional materials; (3) as a result of the foregoing, the Company's disclosure controls and procedures were defective; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/656059/CLASS-ACTION-UPDATE-for-PRVB-WPG-and-RCAR-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESSWIRE

DK